0001104659-21-095504.txt : 20210723 0001104659-21-095504.hdr.sgml : 20210723 20210723181017 ACCESSION NUMBER: 0001104659-21-095504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210721 FILED AS OF DATE: 20210723 DATE AS OF CHANGE: 20210723 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adair Jason CENTRAL INDEX KEY: 0001747055 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39724 FILM NUMBER: 211111820 MAIL ADDRESS: STREET 1: C/O LIQUIDIA TECHNOLOGIES, INC. STREET 2: 419 DAVIS DRIVE, SUITE 100 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Liquidia Corp CENTRAL INDEX KEY: 0001819576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851710962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 110085 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919.328.4400 MAIL ADDRESS: STREET 1: P.O. BOX 110085 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 4 1 tm2123135-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-07-21 0 0001819576 Liquidia Corp LQDA 0001747055 Adair Jason 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 0 1 0 0 V.P. Crp Dvlpmnt and Strtgy Stock Option (Right to Buy) 2.54 2021-07-21 4 A 0 10000 0 A 2031-07-21 Common Stock 10000 10000 D The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on July 21, 2025; provided, however, that notwithstanding the foregoing vesting schedule, 50% of the shares of common sock underlying the option will vest upon U.S. Food and Drug Administration (FDA) tentative approval of the Issuer's New Drug Application for LIQ861. /s/ Jason Adair 2021-07-23